Eva Aguilera

4.4k total citations
34 papers, 540 citations indexed

About

Eva Aguilera is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Eva Aguilera has authored 34 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Genetics and 16 papers in Surgery. Recurrent topics in Eva Aguilera's work include Diabetes and associated disorders (19 papers), Diabetes Management and Research (17 papers) and Pancreatic function and diabetes (16 papers). Eva Aguilera is often cited by papers focused on Diabetes and associated disorders (19 papers), Diabetes Management and Research (17 papers) and Pancreatic function and diabetes (16 papers). Eva Aguilera collaborates with scholars based in Spain, Italy and Australia. Eva Aguilera's co-authors include Ignacio Conget, Roser Casamitjana, Ramón Gomis, Anna Sanmartı́, María Luisa Granada, Berta Soldevila, Manel Puig‐Domingo, Silvia Rodríguez-Fernández, Federico Vázquez and Dı́dac Mauricio and has published in prestigious journals such as Diabetes Care, Diabetes and Scientific Reports.

In The Last Decade

Eva Aguilera

34 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Aguilera Spain	16	333	217	217	73	58	34	540
Miriam Cellini Italy	10	380 1.1×	82 0.4×	115 0.5×	54 0.7×	54 0.9×	20	590
Anna Lam Canada	10	213 0.6×	136 0.6×	233 1.1×	21 0.3×	66 1.1×	25	453
Kenshi Wasada Japan	12	164 0.5×	45 0.2×	157 0.7×	28 0.4×	54 0.9×	18	495
D. Brown United Kingdom	4	56 0.2×	133 0.6×	72 0.3×	65 0.9×	48 0.8×	4	314
Tiphaine Vidal-Trécan France	10	85 0.3×	88 0.4×	59 0.3×	36 0.5×	54 0.9×	23	323
Nishant Raizada India	10	94 0.3×	34 0.2×	41 0.2×	44 0.6×	50 0.9×	40	340
Touraine Jl France	11	41 0.1×	48 0.2×	110 0.5×	94 1.3×	86 1.5×	81	395
Sema Hepşen Türkiye	11	213 0.6×	29 0.1×	78 0.4×	22 0.3×	26 0.4×	52	326
Dror Wasserman Israel	10	55 0.2×	119 0.5×	129 0.6×	64 0.9×	64 1.1×	14	377
Giuseppe Ruocco Italy	12	179 0.5×	43 0.2×	27 0.1×	31 0.4×	71 1.2×	18	446

Countries citing papers authored by Eva Aguilera

Since Specialization

Citations

This map shows the geographic impact of Eva Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Aguilera more than expected).

Fields of papers citing papers by Eva Aguilera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Aguilera. The network helps show where Eva Aguilera may publish in the future.

Co-authorship network of co-authors of Eva Aguilera

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Aguilera. A scholar is included among the top collaborators of Eva Aguilera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Aguilera. Eva Aguilera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beato-Víbora, Pilar Isabel, Ana Chico, Jesús Moreno-Fernández, et al.. (2025). Transitioning between automated insulin delivery systems: A focus on personalisation. Diabetes Research and Clinical Practice. 222. 112070–112070. 1 indexed citations

Aguilera, Eva, Maria Carme Vila, Michael W. Olszowy, et al.. (2024). Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes. Journal of Autoimmunity. 145. 103196–103196. 9 indexed citations

Aguilera, Eva, Manuel Durán, María Dolores Ayllón, et al.. (2024). Predicting waitlist dropout in hepatocellular carcinoma: a narrative review. Translational Gastroenterology and Hepatology. 9. 72–72. 1 indexed citations

Beato-Víbora, Pilar Isabel, Ana Chico, Jesús Moreno-Fernández, et al.. (2023). A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care. 47(2). 216–224. 26 indexed citations

Bellido, Virginia, Eva Aguilera, Roque Cardona‐Hernandez, et al.. (2022). Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes. Journal of Diabetes Science and Technology. 17(5). 1326–1336. 20 indexed citations

Rodríguez-Fernández, Silvia, Irma Pujol‐Autonell, Eva Aguilera, et al.. (2020). Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming. Frontiers in Endocrinology. 11. 258–258. 15 indexed citations

Fernández‐García, Diego, Eva Aguilera, Beatríz González, et al.. (2020). 71-LB: Contour Next One Used with the Smartphone Application Contour Diabetes App Improved Self-Management and Adherence without Reducing Quality of Life in Patients with Diabetes. Diabetes. 69(Supplement_1). 1 indexed citations

Deiss, Dorothee, Agnieszka Szadkowska, Debbie Gordon, et al.. (2019). Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System. Diabetes Technology & Therapeutics. 21(5). 254–264. 43 indexed citations

Rodríguez-Fernández, Silvia, Irma Pujol‐Autonell, Mary Cano‐Sarabia, et al.. (2018). Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry. Frontiers in Immunology. 9. 253–253. 63 indexed citations

10.

Granado-Casas, Minerva, Núria Alcubierre, Jordi Real, et al.. (2018). Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus. European Journal of Nutrition. 58(6). 2271–2279. 26 indexed citations

11.

Aguilera, Eva, María Luisa Granada, Berta Soldevila, et al.. (2015). High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with Type 1 Diabetes Mellitus from a Mediterranean area. Acta Diabetologica. 52(4). 773–779. 13 indexed citations

12.

Pellitero, Sílvia, Dolors Tàssies, Eduarda Pizarro, et al.. (2010). Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes. Thrombosis and Haemostasis. 103(3). 630–637. 12 indexed citations

13.

Pellitero, Sílvia, Jordi L. Reverter, Eduarda Pizarro, et al.. (2010). Utilidad de la pulsioximetría en el cribado de la aterosclerosis carotídea en pacientes con diabetes mellitus tipo 2. Medicina Clínica. 135(1). 15–20. 2 indexed citations

14.

Reverter, Jordi L., Susana Holgado, Eva Aguilera, et al.. (2010). Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. Endocrine. 37(3). 467–472. 28 indexed citations

15.

Aguilera, Eva, María Luisa Granada, M.C. Pastor, et al.. (2008). Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.. European Journal of Endocrinology. 158(4). 483–490. 35 indexed citations

16.

Conget, Ignacio, Eva Aguilera, Sílvia Pellitero, et al.. (2005). Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial. Diabetologia. 48(8). 1464–1468. 7 indexed citations

17.

Aguilera, Eva, Roser Casamitjana, Guadalupe Ercilla, et al.. (2004). Clinical characteristics, β‐cell function, HLA class II and mutations in MODY genes in non‐paediatric subjects with Type 1 diabetes without pancreatic autoantibodies. Diabetic Medicine. 22(2). 137–143. 8 indexed citations

18.

Aguilera, Eva, Mónica Recasens, Rosa Morı́nigo, et al.. (2003). Características clínicas, metabólicas, inmunológicas y genotípicas de un grupo de adolescentes y adultos con diabetes mellitus tipo 1A. Inicio y pronóstico a corto plazo. Medicina Clínica. 120(4). 121–124. 1 indexed citations

19.

Recasens, Mónica, Eva Aguilera, Rosa Morı́nigo, et al.. (2003). Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving β-cell function at onset of type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 60(3). 153–159. 20 indexed citations

20.

Recasens, Mónica, et al.. (2001). Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C. Diabetic Medicine. 18(9). 764–767. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact